成人ICU疼痛、焦虑、躁动/镇静、谵妄、制动与睡眠障碍防治临床实践指南的重点更新
该重点更新由重症医学学会(SCCM)多专业工作组(24人,含护士、医师、药师、物理治疗师、心理学家及ICU幸存者)采用GRADE方法制定,聚焦成人ICU焦虑(新主题)、躁动/镇静、谵妄、制动和睡眠障碍五个领域。工作组就五个领域发布5条声明:条件性推荐使用右美托咪定而非丙泊酚镇静、提供增强活动/康复而非常规活动/康复、以及给予褪黑素;对使用苯二氮䓬类治疗焦虑和使用抗精神病药治疗谵妄未能给出推荐。推荐需结合患者临床状态考虑。
要点
- 成人ICU镇静:条件性推荐右美托咪定优于丙泊酚(GRADE条件性推荐)。
- 成人ICU制动管理:条件性推荐提供增强活动/康复而非常规活动/康复(GRADE条件性推荐)。
- 成人ICU睡眠障碍:条件性推荐给予褪黑素(GRADE条件性推荐)。
- 对苯二氮䓬类治疗焦虑,工作组未能给出推荐。
- 对抗精神病药治疗谵妄,工作组未能给出推荐。
适用人群与场景
- 成人ICU患者,涵盖焦虑、躁动/镇静、谵妄、制动和睡眠障碍五个内容领域。
处置流程与药物剂量
- 成人ICU患者镇静:条件性推荐使用右美托咪定而非丙泊酚。
- 成人ICU患者制动:条件性推荐提供增强活动/康复而非常规活动/康复。
- 成人ICU患者睡眠障碍:条件性推荐给予褪黑素。
- 成人ICU患者焦虑:对使用苯二氮䓬类治疗焦虑未能给出推荐。
- 成人ICU患者谵妄:对使用抗精神病药治疗谵妄未能给出推荐。
研究设计与关键结果
- 工作组由24名成员组成,包括护士、医师、药师、物理治疗师、心理学家和ICU幸存者,采用GRADE方法制定循证推荐,并在所有阶段严格执行利益冲突政策。
- 针对成人ICU五个内容领域(焦虑为新主题、躁动/镇静、谵妄、制动、睡眠障碍),对每个PICO问题进行了系统评价、证据统计汇总、证据质量评估,并通过证据到决策框架形成推荐。
- 工作组共发布5条声明,涉及焦虑、躁动/镇静、谵妄、制动和睡眠障碍的管理。
- 条件性推荐使用右美托咪定而非丙泊酚镇静、提供增强活动/康复而非常规活动/康复、以及给予褪黑素。
- 对使用苯二氮䓬类治疗焦虑和使用抗精神病药治疗谵妄未能给出推荐。
证据类型、等级与局限
- 证据类型:临床实践指南重点更新,采用GRADE方法进行系统评价和证据分级。
- 推荐强度:右美托咪定优于丙泊酚、增强活动/康复优于常规活动/康复、给予褪黑素均为条件性推荐。
- 对苯二氮䓬类治疗焦虑和抗精神病药治疗谵妄,工作组未能给出推荐。
- 局限:原文未报告局限性
对床旁实践的改变
- 成人ICU镇静可考虑条件性选择右美托咪定而非丙泊酚。
- 成人ICU制动管理可考虑条件性提供增强活动/康复而非常规活动/康复。
- 成人ICU睡眠障碍可考虑条件性给予褪黑素。
- 对苯二氮䓬类治疗焦虑和抗精神病药治疗谵妄,因证据不足未能给出推荐,临床决策需结合患者临床状态。
指南或共识出处
- 指南名称:A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU(成人ICU疼痛、焦虑、躁动/镇静、谵妄、制动与睡眠障碍防治临床实践指南重点更新)。
- 发布机构:Society of Critical Care Medicine(SCCM)。
- 更新基础:SCCM 2018年临床实践指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Critically ill adults are at risk for a variety of distressing and consequential symptoms both during and after an ICU stay. Management of these symptoms can directly influence outcomes.
OBJECTIVES: The objective was to update and expand the Society of Critical Care Medicine's 2018 Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.
PANEL DESIGN: The interprofessional inclusive guidelines task force was composed of 24 individuals including nurses, physicians, pharmacists, physiotherapists, psychologists, and ICU survivors. The task force developed evidence-based recommendations using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Conflict-of-interest policies were strictly followed in all phases of the guidelines, including task force selection and voting.
METHODS: The task force focused on five main content areas as they pertain to adult ICU patients: anxiety (new topic), agitation/sedation, delirium, immobility, and sleep disruption. Using the GRADE approach, we conducted a rigorous systematic review for each population, intervention, control, and outcome question to identify the best available evidence, statistically summarized the evidence, assessed the quality of evidence, and then performed the evidence-to-decision framework to formulate recommendations.
RESULTS: The task force issued five statements related to the management of anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adults admitted to the ICU. In adult patients admitted to the ICU, the task force issued conditional recommendations to use dexmedetomidine over propofol for sedation, provide enhanced mobilization/rehabilitation over usual mobilization/rehabilitation, and administer melatonin. The task force was unable to issue recommendations on the administration of benzodiazepines to treat anxiety, and the use of antipsychotics to treat delirium.
CONCLUSIONS: The guidelines task force provided recommendations for pharmacologic management of agitation/sedation and sleep, and nonpharmacologic management of immobility in critically ill adults. These recommendations are intended for consideration along with the patient's clinical status.
参考来源
- Lewis K, Balas MC, Stollings JL, et al. A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2025. PMID: 39982143. doi:10.1097/CCM.0000000000006574
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。